These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29868117)

  • 1. Deep Sequencing Revealed a CpG Methylation Pattern Associated With
    Beniaminov AD; Puzanov GA; Krasnov GS; Kaluzhny DN; Kazubskaya TP; Braga EA; Kudryavtseva AV; Melnikova NV; Dmitriev AA
    Front Genet; 2018; 9():169. PubMed ID: 29868117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Silencing of ALDH1L1, a Metabolic Regulator of Cellular Proliferation, in Cancers.
    Oleinik NV; Krupenko NI; Krupenko SA
    Genes Cancer; 2011 Feb; 2(2):130-9. PubMed ID: 21779486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
    Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.
    Kang JH; Kim SJ; Noh DY; Park IA; Choe KJ; Yoo OJ; Kang HS
    Lab Invest; 2001 Apr; 81(4):573-9. PubMed ID: 11304577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation-dependent silencing of CST6 in human breast cancer cell lines.
    Rivenbark AG; Jones WD; Coleman WB
    Lab Invest; 2006 Dec; 86(12):1233-42. PubMed ID: 17043665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
    Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of expression level and methylation profile of
    Mohammadi Z; Azad M; Foroughi F; Khojastehpour S; Gheibi N; Samiee-Rad F; Maali A; Ahmadi MH
    J Cancer Res Ther; 2021; 17(6):1328-1334. PubMed ID: 34916361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter Methylation Changes in
    Chen Y; Bao Z; Liu M; Li J; Dai Y; Wang F; Zhang X; Zhai P; Zhao B; Wu X
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.
    Zheng F; Hasim A; Anwer J; Niyaz M; Sheyhidin I
    Mol Biol Rep; 2013 Mar; 40(3):2069-75. PubMed ID: 23283737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisulfite profiling of the MGMT promoter and comparison with routine testing in glioblastoma diagnostics.
    Tierling S; Jürgens-Wemheuer WM; Leismann A; Becker-Kettern J; Scherer M; Wrede A; Breuskin D; Urbschat S; Sippl C; Oertel J; Schulz-Schaeffer WJ; Walter J
    Clin Epigenetics; 2022 Feb; 14(1):26. PubMed ID: 35180887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation.
    Tong SY; Ki KD; Lee JM; Kang MJ; Ha TK; Chung SI; Chi SG; Lee SK
    Acta Obstet Gynecol Scand; 2010 May; 89(5):629-35. PubMed ID: 20423276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylation.
    Imagawa K; de Andrés MC; Hashimoto K; Itoi E; Otero M; Roach HI; Goldring MB; Oreffo RO
    Arthritis Rheumatol; 2014 Nov; 66(11):3040-51. PubMed ID: 25048791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
    Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
    Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Downregulation of OGDHL expression is associated with promoter hypermethylation in colorectal cancer].
    Fedorova MS; Kudryavtseva AV; Lakunina VA; Snezhkina AV; Volchenko NN; Slavnova EN; Danilova TV; Sadritdinova AF; Melnikova NV; Belova AA; Klimina KM; Sidorov DV; Alekseev BY; Kaprin AD; Dmitriev AA; Krasnov GS
    Mol Biol (Mosk); 2015; 49(4):678-88. PubMed ID: 26299868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.